ABSTRACT Aims/Introduction: Pregnant women with gestational diabetes mellitus (GDM) are at a higher risk of adverse pregnancy outcomes. The aim of the present study was to estimate the pooled prevalence of GDM in mainland China according to International Association of Diabetes and Pregnancy Study Groups criteria. Materials and Methods: We carried out a systematic review by searching both English and Chinese literature databases. Random effects models were used to summarize the prevalence of GDM in mainland China. Subgroup and sensitivity analyses were carried out to address heterogeneity. Publication bias was evaluated using Egger's test. Results: A total of 25 papers were included in the meta-analysis, involving 79,064 Chinese participants. The total incidence of GDM in mainland China was 14.8% (95% confidence interval 12.8-16.7%). Subgroup analysis showed that the age, bodyweight and family history of diabetes mellitus could significantly increase the incidence of GDM. Conclusions: To the best of our knowledge, this systematic review is the first to estimate the pooled prevalence of GDM among women in mainland China according to International Association of Diabetes and Pregnancy Study Groups criteria. The results of our systematic review suggest a high prevalence of GDM in mainland China, indicating that this country might have the largest number of GDM patients worldwide.
INTRODUCTION
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance resulting in hyperglycemia with first onset or detection during pregnancy. GDM is seriously harmful to both the woman and the fetus. Pregnant women and puerperae are prone to complications of gestational hypertensive disease, polyhydramnios, premature rupture of fetal membranes, infection and premature birth; in severe cases, ketoacidosis can occur, and puerperae might have long-term postpartum diabetes 1, 2 . In addition, the fetus is prone to spontaneous abortion, malformation and hypoxia; in severe cases, intrauterine death can occur. Hyperglycemia tends to cause fetal macrosomia; the chances of dystocia at parturition are increased, and the newborn is prone to neonatal respiratory distress syndrome, hypoglycemia and other complications after birth, including death in severe instances 3 . In 2008, the hyperglycemia and adverse pregnancy outcome (HAPO) study, which involved multiple countries, showed that at 24-32 weeks-of-gestation, a higher blood glucose level in the 75-g oral glucose tolerance test (OGTT) indicates a greater risk of adverse gestational outcomes. Indeed, even with a normal blood glucose level, the risk of having an adverse outcome for both mother and baby is greater with an increase in blood glucose level, whereas significant thresholds were not observed for most comorbidities. Based on that study, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed new GDM diagnostic criteria in 2010: boundary blood glucose levels for fasting, 1 and 2 h after oral glucose of 5.1, 10.0 and 8.5 mmol/L, respectively, by 75-g OGTT. If any one of these three values reaches or exceeds the boundary level, the patient should be diagnosed with GDM 4 . The publication of this diagnostic standard had a "milestone" significance. In 2011, the American Diabetes Association (ADA) recommended the IADPSG criteria be adopted as GDM diagnostic criteria, and in August 2013, the World Health Organization (WHO) used the HAPO study results as an important reference to develop new GDM diagnostic criteria 5 . In 2014, the ADA once again noted that although the new diagnostic criteria would increase healthcare costs, they might also reduce the incidence of adverse gestation events, especially for pregnant women with slightly high blood glucose levels. In October 2015, the International Federation of Gynecology and Obstetrics published a practical guide to GDM, which also utilizes the IADPSG criteria to diagnose GDM 6 . As a result of economic development and improvements in living standards, together with increased attention to GDM screening, an increase has been observed in the incidence of GDM. China has a high incidence of diabetes, and the increase in GDM incidence in China is also alarming. Furthermore, China encompasses a vast territory, and has a large population with considerable differences in regions, ethnicities, diets and living habits, and these factors lead to differences in the incidence of GDM reported in various regions. For example, studies have found that even if the IADPSG diagnostic criteria are applied, the incidence of GDM in mainland China fluctuates between 5.12% and 33.3% 7, 8 . As there is currently no systematic analysis of the incidence of GDM in China, the present study aimed to explore the incidence of GDM among pregnant women in mainland China, and the impact of relevant factors on GDM incidence through a systematic meta-analysis.
METHODS
A completed Preferred Reporting Items for Systematic Review and Meta-Analyses checklist is presented in Data S1.
Search strategy
We searched for epidemiological studies on GDM in several electronic databases, including Medline, PubMed, China National Knowledge Infrastructure, Wanfang and Chongqing VIP. ; China National Knowledge Infrastructure: AB = gestational diabetes mellitus AND (AB = prevalence OR AB = epidemiology); Wangfang: Abstract: (gestational diabetes mellitus)* (prevalence + epidemiology). Chongqing VIP: R = gestational diabetes mellitus*(R = prevalence + R = epidemiology). All studies published from 1 January 2010 to 30 April 2017, were searched. In addition, the reference lists of the retrieved articles were examined to identify additional eligible studies. Unpublished studies were not retrieved. The search languages were limited to English and Chinese.
Inclusion and exclusion criteria
To satisfy the analysis requirements and to reduce selection deviation, studies needed to meet the following criteria for inclusion: (i) a cross-sectional study or retrospective study collected in mainland China; (ii) sufficient information on the sample size and crude prevalence of GDM; (iii) GDM diagnostic criteria proposed by IADPSG in 2010 4 ; (iv) containing information for at least family history of diabetes mellitus, body mass index (BMI), age, pregnancy history and delivery history. Studies were excluded if they recruited patients with serious and chronic diseases, including thyroid disease, heart disease and overt diabetes mellitus. In the case of multiple articles based on the same population, only the study reporting the most detailed data was included.
Data extraction and quality assessment All searched articles from different electronic databases were combined in Endnote, and duplicates were removed. Two researchers independently screened the title and abstract, and reviewed the full text of eligible citations. In the case of disagreement, a third reviewer made the final decision. For each included study, the two researchers independently extracted the following information: general information (e.g., first author and publication year), study characteristics (including study period, study area and sample size) and all possible participant information (e.g., age, family history of diabetes mellitus, BMI, region etc.). The two researchers independently assessed the quality of each included study using the Newcastle-Ottawa Scale recommended by the Cochrane Handbook for Systematic Reviews of Interventions.
Statistical analysis
We used a systematic analysis approach to calculate the pooled prevalence of GDM for all eligible studies. A random effects model was selected to summarize the prevalence of GDM; heterogeneity among studies was assessed using Cochran's Qtest and the I 2 statistic, which shows the percentage of variation across studies. Subgroup analyses by age, family history of diabetes mellitus, BMI, region and so on were carried out to address heterogeneity. Additionally, sensitivity analysis was carried out to examine the influence of any particular study on the pooled estimate. Publication bias was evaluated using Egger's test, and independent t-tests were carried out as appropriate. The significance level was set at a P-value of <0.05. All statistical analyses were carried out using Stata version 12.0 (StataCorp, College Station, TX, USA) and SPSS version 20.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The initial search retrieved 2,576 records from Medline, PubMed, China National Knowledge Infrastructure, Wanfang and Chongqing VIP databases, and 508 articles remained after excluding duplicates, reviews and letters. After screening for eligibility based on the title and abstract, 107 articles were selected; of these, 25 articles were included after screening the full text. The main reasons for inclusion in the full-text selection are shown in Figure 1 . The 25 articles that met the requirements and were eventually included in the study covered Table 1 . Among the included articles, 24 focused on women of Han nationality, one involved other ethnic groups and two included a multiple pregnancy. The economic levels of the regions in the included papers had per capita annual incomes ranging from less than $US1,000 to $US30,000, and the papers included age, family history of diabetes mellitus, history of pregnancy and delivery, BMI, per capita income, and many other factors that affect GDM. In accordance with the recommended criteria of the Newcastle-Ottawa Scale, the studies included in the present meta-analysis were of acceptable quality; therefore, we did not exclude any article from the meta-analysis for quality reasons.
The total incidence of GDM in mainland China was 14.8% (95% confidence interval [CI] 12.8-16.7%; Figure 2 ). Table 2 shows the results of subgroup analysis in different groups. Subgroup analysis showed an incidence of GDM in older pregnant women of 26.7% (95% CI 23.2-30.3%), whereas that in younger pregnant women was just 13.4% (95% CI 11.0-15.7%), with a significant difference between the two subgroups (P < 0.01). The incidence of GDM in overweight or obese women was 30.3% (95% CI 25.9-34.7%), which was significantly higher than that of women who had a normal bodyweight (14.9%, 95% CI 11.7-18.1%; P < 0.01). The incidence of GDM in women with a family history of diabetes mellitus was 32.9% (95% CI 27.5-38.4%), approximately threefold that in women without a family history (P < 0.01). Using the per capita income of $US10,000 as a boundary, the regional economic level did not have a significant impact on the incidence of GDM (14.8% and 15.4%, P = 0.53). We carefully and comprehensively searched the articles in the database. Sensitivity analysis was carried out to examine the influence of any particular The economic levels of the regions in the included papers had per capita annual incomes ranging from less than $US1,000 to $US30,000, and we used the per capita income of $US10,000 as a boundary between low and high. 
DISCUSSION
As early as 1964, O'Sullivan and Mahan 32 suggested screening for high-risk pregnant women and, for the first time, proposed diagnostic criteria for GDM, whereby patients should be diagnosed with GDM when blood glucose levels are equal to or greater than boundary values for fasting, 1, 2 and 3 h after oral glucose of 5.0, 9.2, 8.1 and 7.0 mmol/L, respectively, according to the 100-g OGTT. In 1973, O'Sullivan et al 33 proposed a 50-g OGTT; if the blood glucose level was ≥7.2 mmol/L 1 h after glucose load, then the 100-g OGTT was carried out. The results of a number of subsequent studies showed that for GDM screening, it is most suitable to use 7.8 mmol/L as the boundary value for a blood glucose level at 1 h after glucose load, a value that is still used today. In 1979, the National Diabetes Data Group modified the diagnostic criteria of GDM based on O'Sullivan's standard 34 . In this case, the patient should be diagnosed with GDM when plasma glucose levels are ≥2 boundary points of the values for fasting, 1, 2 and 3 h after glucose load of 5.8, 10.6, 9.2 and 8.1 mmol/L, respectively. In 1982, Carpenter 35 recommended that the plasma glucose boundary values for fasting, 1, 2 and 3 h after taking glucose be 5.3, 10.0, 8.6 and 7.8 mmol/L, respectively, with GDM diagnosis at levels ≥2 boundary points. In 1998, this standard was recommended for application by the ADA, but the glucose load was changed from 100 to 75 g, and the 3-h blood glucose value was removed. As guidelines for the diagnosis and classification of diabetes were issued by the WHO in 1965, in 1999, it recommended after three discussions that patients should be diagnosed with GDM when fasting plasma glucose is ≥7.0 mmol/L or 2-h blood glucose is 11.1 mmol/L. Although the NDGG, ADA and WHO standards have been used for many years, for the past 50 years, the diagnostic methods and standards for GDM have been the subject of controversy. Both the standard proposed by O'Sullivan and the later National Diabetes Data Group or ADA standard are all based on the risk of a pregnant woman developing type 2 diabetes, but these standards lacked any consideration of gestational outcome. The WHO standard, which directly evolved from the non-pregnant standard, also had shortcomings when it was directly applied to pregnancy. In 2010, the IADPSG proposed a new standard for GDM diagnosis based on the HAPO study, and in this same year, the ADA The present study is the first meta-analysis of the incidence of GDM according to the IADPSG standard in mainland China. This study found an incidence of GDM in mainland China of 14.8%, which is similar to the reported incidence of GDM in Hong Kong -14.4% by the HAPO multicenter study 36 . Although the incidence of GDM in mainland China is lower than that in the USA, Singapore and other developed nations, considering China's huge population, it is speculated that China might have the largest number of GDM patients. In addition, the incidence of GDM in China shows a clear upward trend. For example, the incidence of GDM in Tianjin, China, increased almost threefold from 1999 to 2008. Therefore, closer attention should be paid to GDM in China 37 .
The results of subgroup analysis showed that the incidence of GDM in older women in China was 26.7%, though the incidence of GDM in younger women was just 13.4%; thus, the incidence of GDM among older women was approximately twice that among younger women. As China's fertility policy changes, divorce and remarriage rates increase, and multiparous women might have more children due to the death of offspring as a result of disease or accidents; thus, the incidence of advanced maternal age among pregnant women will continue to increase in China. Apart from the factor of age, the incidence of GDM in women with a family history of diabetes was threefold as high as that of women without a family history, suggesting that a family history of diabetes significantly increases the incidence of GDM. In addition, overweight or obesity also showed significant impacts on the incidence of GDM. Conversely, we found that the per capita economic levels of the 21 cities included did not influence the incidence of GDM. We suggest that this apparent lack of influence might be related to the mixed effects of diet, lifestyle, region and many other factors. China is a multi-ethnic country, with the Han nationality as the main group. In the present study, the incidence of GDM among women of the Kirgiz nationality of Xinjiang was lower than that of the Han nationality, but only one study was included. In addition, some studies have found the incidence of GDM in multiparous women to be higher than that of women with a single pregnancy; again, the sample size was small, and thus, further study is required.
The limitation of the present study was that the main data from the studies included were from large-scale comprehensive hospitals and specialist hospitals; as only a few studies were multicenter, multilevel studies, the data lacked results from grass-roots hospitals. Furthermore, the study participants were mainly from urban populations; studies on the prevalence of GDM in pregnant women in China's rural areas are rare, which will impact the calculation of the total prevalence of GDM in mainland China. We hope that there will be more epidemiological studies on GDM in grass-roots hospitals and in rural populations in the future.
To the best of our knowledge, the present systematic review is the first to estimate the pooled prevalence of GDM among women in mainland China according to IADPSG criteria. The results of the present systematic review suggest that the total incidence of GDM in mainland China is 14.8%, indicating that China might have the largest number of GDM patients. Therefore, more attention should be paid to the prevention and control of GDM.
